BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 766923)

  • 1. The ability of ALS against lymph node lymphocyte subpopulations to prolong the skin allograft survival in mice.
    Rudnicka W; Gościcka T; Szewczyk K; Zelazowski P; Zablocki B
    Bull Acad Pol Sci Biol; 1976; 24(1):27-31. PubMed ID: 766923
    [No Abstract]   [Full Text] [Related]  

  • 2. The ability of syngeneic spleen cells coated with antilymphocyte antibodies in vitro to prolong the skin allograft survival in mice.
    Rudnicka W
    Bull Acad Pol Sci Biol; 1979; 27(12):1015-20. PubMed ID: 399869
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression of skin allograft rejection by post-transplantation administration of specific anti-lymphocyte serum.
    Sundaresan P; Sainis KB; Phondke GP; Sundaram K
    Immunol Lett; 1986 Apr; 12(4):201-5. PubMed ID: 3522415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of heterologous antilymphocyte serum on the formation of H-2 antibody and the induction of allograft immunity.
    Monaco AP; Franco DJ
    Transplant Proc; 1969 Mar; 1(1):474-8. PubMed ID: 4944263
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of antilymphocyte serum on the thymus.
    Levey RH; Taub R
    Transplant Proc; 1969 Mar; 1(1):424-8. PubMed ID: 4944253
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
    Gozzo JJ; Wood ML; Pompei R; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphocyte ecology and immunologic tolerance.
    Levey RH
    Transplant Proc; 1973 Mar; 5(1):893-6. PubMed ID: 4572152
    [No Abstract]   [Full Text] [Related]  

  • 8. A more specific rabbit antimouse lymphocyte serum.
    Miller J; Cohn RB
    Surg Forum; 1969; 20():257-9. PubMed ID: 4910590
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphocyte recruitment properties of regional lymph node or spleen cells during skin allograft rejection.
    Hanto DW; Harty JT; Simmons RL
    Transplantation; 1983 Nov; 36(5):578-81. PubMed ID: 6356522
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to phytohaemagglutinin of lymphocytes from mice treated with anti-lymphocyte globulin.
    Tursi A; Greaves MF; Torrigiani G; Playfair JH; Roitt IM
    Immunology; 1969 Nov; 17(5):801-11. PubMed ID: 4900922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-dependence of ALS effects on immunological and haematopoietic activities in mice.
    Nouza K; Haskovcová H; Nĕmec M
    Folia Biol (Praha); 1971; 17(5):312-21. PubMed ID: 4399318
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on heterologous antilymphocyte serum in mice. 8. Effect of immunizing cell type and dose on immunosuppressive potency and content of irrelevant antibody.
    Gozzo JJ; Wood ML; Monaco AP
    Transplantation; 1972 Sep; 14(3):352-7. PubMed ID: 4564931
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of cytotoxic (sensitization) and enhancing (prolonged survival) responses by injection of lymphoid cells in ALS-treated mice.
    Wood ML; Monaco AP
    Transplant Proc; 1979 Jun; 11(2):1456-7. PubMed ID: 382539
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte environment and the durability of transplantation tolerance.
    Levey RH
    Transplant Proc; 1972 Sep; 4(3):395-9. PubMed ID: 4404152
    [No Abstract]   [Full Text] [Related]  

  • 15. [Response of the lymphoid system to skin allotransplantation following administration of ALS against normal and passively sensitized lymphocytes].
    Fedorich VN
    Fiziol Zh; 1977; 23(6):837-9. PubMed ID: 338372
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of heterologous antilymphocyte serum on lymphoid cells labeled with 5-iodo-2-deoxyuridine-125-I.
    Taub RN
    Fed Proc; 1970; 29(1):142-4. PubMed ID: 4904619
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vitro quantitative determination of the cellular response to skin allografts in mice].
    Degiovanni G
    C R Seances Soc Biol Fil; 1972; 166(4):722-7. PubMed ID: 4568591
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of posttransplant-administered peripheral blood lymphocytes for prolonging allograft survival in ALS-treated mice.
    Gozzo JJ; Monaco AP; De Fazio SR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):269-70. PubMed ID: 2650116
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of ALS on transplanted lymph node cells: determination of time required for inactivation of CFU by allogeneic lymphocytes.
    Manyko VM; Petrov RV; Sidorovich IG; Kraskina NA
    Folia Biol (Praha); 1973 Sep; 19(5):305-14. PubMed ID: 4772340
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytotoxic activity of lymph node cells from mice treated with immunosuppressive antilymphocyte serum.
    Smith JJ; Green SS; Sell KW
    Proc Soc Exp Biol Med; 1972 Feb; 139(2):704-8. PubMed ID: 4550941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.